Published • loading... • Updated
RNAV8 Bio Joins ARPA-H Team to Pioneer Programmable RNA Medicines
RNAV8 Bio (pronounced Renovate Bio) has been selected to receive funding from the Advanced Research Projects Agency for Health (ARPA-H) for PROPEL (Programmable RNA for Optimal Precision in Therapeutic Efficacy and Localization). RNAV8, a biofirm applying AI-driven design and laboratory validation to engineer more predictable mRNA medicines, will be part of a team led by the Rouskin Lab at Harvard Medical School with the Weissman Lab at MIT/the …
1 Articles
1 Articles
RNAV8 Bio Joins ARPA-H Team to Pioneer Programmable RNA Medicines
RNAV8 Bio (pronounced Renovate Bio) has been selected to receive funding from the Advanced Research Projects Agency for Health (ARPA-H) for PROPEL (Programmable RNA for Optimal Precision in Therapeutic Efficacy and Localization). RNAV8, a biofirm applying AI-driven design and laboratory validation to engineer more predictable mRNA medicines, will be part of a team led by the Rouskin Lab at Harvard Medical School with the Weissman Lab at MIT/the …
·New Rochelle, United States
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
